Vaginal Discharge & STI Screen
Red Flags — when discharge is not "just thrush"
| Red flag | Why dangerous | Action |
|---|---|---|
| Post-coital / intermenstrual bleeding, or a suspicious-looking cervix | Can be infective (cervicitis) but is a recognised presentation of cervical cancer. A normal smear does not exclude cancer. The cervix must be visualised; a friable, irregular or contact-bleeding cervix needs urgent referral. | Examine cervix; urgent suspected cervical cancer referral (NICE NG12) if appearance suspicious |
| PID — pelvic pain, deep dyspareunia, abnormal bleeding, cervical motion/adnexal tenderness | Delayed treatment risks tubal infertility, ectopic pregnancy and chronic pain. Have a low threshold to treat empirically. | Empirical PID antibiotics; exclude ectopic/pregnancy; partner treatment; safety-net |
| Pregnancy with pain/bleeding | Ectopic pregnancy is life-threatening and can mimic PID/STI symptoms; never attribute pain/bleeding in a possibly pregnant woman to infection without excluding ectopic. | Pregnancy test; urgent assessment / EPU if ectopic possible |
| Systemic sepsis / tubo-ovarian abscess | Severe PID with fever, severe pain, peritonism or a pelvic mass can become life-threatening. | Same-day admission; IV antibiotics; gynaecology |
| Safeguarding — under 16, coercion, exploitation, FGM, abuse | Sexual-health presentations in young or vulnerable people may be the only window onto abuse or exploitation; missing it has lifelong consequences. | Safeguarding assessment; involve safeguarding lead; document; refer as indicated |
| Possible disseminated/complicated gonococcal or syphilis | Untreated gonorrhoea/syphilis can disseminate; resistant gonorrhoea needs specialist management and culture for sensitivities. | GUM referral; culture for gonorrhoea sensitivities; treat per BASHH |
🔒 Confidentiality
Explicit reassurance about confidentiality (and its limits in safeguarding) is the foundation of an honest sexual history — especially for young people.
"Everything we talk about here is confidential. The only time I'd ever need to share anything is if I were worried about your safety — and I'd talk to you first."🙅 Reluctance to be examined
Offer the self-taken vulvovaginal swab to lower the barrier; explain when an examination is genuinely needed (the bleeding) and let her retain control.
"For the infection tests you can take the swab yourself — it's just like inserting a tampon. The one thing I would like to look at, because of the bleeding after sex, is your cervix — but we can talk that through and you're always in control."💬 Non-judgmental partner notification
Framing partner notification as routine and blame-free (and offered via the clinic/GUM) makes it acceptable and protects others.
"If a test is positive, we'd want to let recent partners know so they can be treated too — that can be done completely anonymously through the sexual-health service. It's routine and nobody is blamed."⚕️ Future fertility framing
Linking testing to protecting her future fertility (untreated chlamydia → PID → tubal damage) gives a positive, personal reason to test.
"One reason I'm keen to test rather than guess is that some infections, if missed, can quietly affect fertility later — testing now is the best way to protect that."The new relationship
A two-month relationship is often the point when condoms are dropped and when a positive STI result feels most threatening — "does this mean he's been unfaithful?" or "will he think I have?" Many patients avoid testing to avoid that conversation. Explain that chlamydia can be carried silently for months or years, so a positive result rarely tells you who acquired it from whom or when.
"Infections like chlamydia can sit quietly for a long time without symptoms, so a positive test doesn't tell us who had it first. It's about getting you both treated, not about blame."Culture, faith and family
For some patients, sex outside marriage or a new relationship carries family, cultural or religious weight, and confidentiality from relatives (including relatives registered at the same practice, or who may see a prescription or letter) is a real concern. Do not assume — ask how she would like results and contact handled (which phone number, whether a message can be left, text vs call).
"How would you like us to get in touch about results? Is it okay to text this number, or would you rather we only call you directly?"Coercion and domestic abuse
Recurrent STIs, requests for repeated emergency contraception, a partner who controls contraception or condom use, or reluctance to be seen alone can signal intimate-partner violence or reproductive coercion. Ask routinely and privately, not only when there is a visible sign. If she discloses, the plan changes — safety, IDVA/local domestic abuse services, documentation that the partner cannot access, and care with partner notification.
"I ask everyone this: does anyone ever pressure you into sex, or stop you using contraception or condoms when you want to?"Young people
Under-16s can consent to STI testing and treatment if Gillick competent, and to contraception if the Fraser criteria are met; confidentiality is maintained unless there is a risk of serious harm. Every under-18 needs a proportionate child sexual exploitation assessment (age and age of partner, gifts or money, alcohol or drugs, older "boyfriend", going missing, repeat STIs or emergency contraception). A child under 13 cannot consent to sexual activity in law (Sexual Offences Act 2003) — disclosure of sexual activity or an STI in an under-13 means a safeguarding referral every time.
"You can see me on your own and what we talk about stays private. The only time I'd need to share anything is if I thought you or someone else was at risk of serious harm — and I'd talk to you about it first."Previous experiences of examination
Reluctance to be examined may be embarrassment, but it may also reflect previous sexual trauma, vaginismus, FGM, or a painful previous speculum examination. Offering a self-taken swab, a clinician of her preferred gender, a chaperone, a smaller speculum, and explicit permission to stop are trauma-informed defaults, not concessions.
"Some people find examinations difficult for all sorts of reasons, and you don't have to tell me why. You're in control — we can stop at any point, and if today isn't right we can plan another time."Time, work and access
"I'm in a rush" is often real: an office job, a lunch-break appointment, the difficulty of getting back for results. Make the efficient path the safe path — self-swab and bloods today, results by text, the examination booked at a time that suits her (with a clear reason why it should not wait long), and direct booking or online self-sampling from the local sexual health service where available.
"I know you're short of time. If we do the swab and the blood test now, the results come to your phone — and we'll find a time that works for the examination this week."- Prescribing thrush treatment without a sexual history or considering STI/BV
- Ignoring post-coital bleeding / not examining the cervix
- Omitting safeguarding assessment in a young person
- Judgmental or rushed manner that shuts down the history
Same day / 999
Immediate action- Possible ectopic pregnancyPain/bleeding + positive/possible pregnancy → urgent EPU/gynae
- Severe PID / tubo-ovarian abscess / sepsisFever, severe pain, peritonism, mass → admit
- Acute safeguarding riskExploitation/abuse with immediate risk → safeguarding emergency pathway
Days–2 weeks
Prompt action- Suspicious-looking cervixSuspected cancer pathway referral (NICE NG12); persistent unexplained PCB/IMB with a normal cervix → gynae/colposcopy per local pathway
- PID (clinical)Empirical antibiotics now; partner treatment; review
- Safeguarding concern (non-acute)Safeguarding lead; document; refer
GP / sexual health
Primary care first-line- BV / candidaTreat per features; advice on recurrence
- STI screen (asymptomatic risk / discharge)NAAT self-swab + HIV/syphilis; treat + partner notification
- Uncomplicated chlamydiaDoxycycline; partner notification; test of cure if indicated
- Missing ectopic in a possibly pregnant woman with pain/bleeding
- Not recognising PID needs prompt empirical treatment
- Reassuring on PCB because of a recent normal smear
- Not examining the cervix despite post-coital bleeding
- No chaperone / consent not documented
- Reflex examination when self-swab would suffice for a low-risk candida/BV picture
- Treating empirically for an STI without NAAT testing
- Not offering HIV/syphilis in an at-risk patient
- Forgetting partner notification / test of cure
🚩 The discipline — treat the infection, but examine the bleeding
The trap is to find an infective cause (BV or chlamydia), treat it, and attribute the post-coital bleeding to that — without ever looking at the cervix. Cervical cancer is repeatedly missed this way. For Aisha, the formulation is: characterise and test the discharge (likely BV ± STI given the risk), AND examine the cervix because of the post-coital bleeding — referring urgently under NG12 if it looks suspicious, independent of her recent normal smear.
- Attributing PCB to infection without examining the cervix
- Reassuring purely on a recent normal smear
- Not knowing/actioning the NG12 cervical pathway
- Missing the need for GUM contact tracing in confirmed STI
Validate — name the expectation and the hurry
Aisha expects a prescription for thrush and a short appointment. She has had thrush before, so her self-diagnosis is reasonable on its face, and her time pressure is real. Naming both out loud tells her you have heard her before you ask anything of her — and makes it much less likely that the rest of the plan feels like an obstacle course.
"You've had thrush before, so it makes complete sense that you thought this was the same thing — and I can see you're short of time. Let me explain why I don't think this one is thrush, and then we'll find the quickest way to sort it."Explain — share the reasoning in her own terms
Three things she told you do not fit thrush: the discharge is watery rather than thick, there is a smell, and it does not itch. Together they point towards bacterial vaginosis, which needs a different medicine — thrush cream will not work. The new partner and inconsistent condoms mean a sexual-health check is sensible, and the bleeding after sex needs the cervix looked at whatever the swabs show. Keep the explanation to these three plain points; resist a lecture.
"Thrush is usually thick, white and itchy. What you're describing — watery, with a smell and no itch — sounds more like a bacterial imbalance called BV, and thrush cream won't treat that. Because there's a new partner, I'd also like to check for infections that often have no symptoms. And the bleeding after sex is the one thing I don't want to guess about."Negotiate — something today, and control over the rest
She should leave with something concrete: a treatment for the likely BV if the picture fits, a self-taken swab done in the toilet next door, bloods for HIV and syphilis if she agrees, results by text, and the examination either now with a chaperone or booked at a time she chooses within the next few days. If she declines part of the plan, record that she was informed, keep the door open, and still safety-net — autonomy is respected, not punished.
"Here's what I suggest: you do a quick swab yourself, I'll treat the likely cause today, and the results come to your phone. I would really like to look at your cervix because of the bleeding — we can do that now with a chaperone, or book it for a time that suits you this week. What would work best?"Lactobacilli keep the vagina acidic (pH ≤4.5) by producing lactic acid; that acidity suppresses the anaerobes that cause BV. Douching, antiseptics, perfumed washes, bubble bath and vaginal deodorants strip lactobacilli and raise pH — the very conditions in which BV recurs. Irritants also cause a contact vulvitis that is easily mistaken for thrush.
Ask directly — many patients douche because they notice odour, which worsens the cycle. Advise washing the vulva with water or an unperfumed emollient and never washing inside the vagina. Explain that BV is not caused by poor hygiene; over-washing is more often the problem.
Condoms reduce transmission of chlamydia, gonorrhoea, trichomonas and HIV, and semen raises vaginal pH, so condom use is also associated with fewer BV recurrences. A new relationship is the natural moment both partners test and agree when to stop using condoms.
Frame it as routine: "many couples both get tested at the start of a relationship." Warn that clindamycin cream and clotrimazole vaginal products can damage latex condoms and diaphragms — use another method during and shortly after treatment (check product information). Free condoms are available through local sexual health services and C-Card schemes for young people.
Aisha sometimes misses her pill. Missed pills plus unprotected sex create a pregnancy risk that changes drug choice (no metronidazole 2 g stat, no fluconazole, no doxycycline) and makes ectopic pregnancy part of any pain-and-bleeding differential. Metronidazole and doxycycline are not enzyme inducers and do not reduce the effectiveness of hormonal contraception.
Do a pregnancy test today. If recent missed pills and unprotected sex put her at risk, apply CoSRH missed-pill rules (emergency contraception if indicated; repeat a pregnancy test at least 3 weeks after the last unprotected sex). Offer long-acting reversible contraception — if she chooses a copper IUD, note it is associated with BV, and intrauterine contraception should not be fitted with untreated symptomatic infection or cervicitis.
Most chlamydia and much gonorrhoea is asymptomatic, so symptoms are a poor guide to infection. Testing at partner change and retesting after a positive result find reinfection before it ascends to cause PID.
Tell her about free online self-sampling kits from her local sexual health service. If chlamydia is positive, arrange a retest for reinfection at about 3 months (NCSP recommendation for under-25s; the BASHH 2026 guideline allows 2–6 months). Offer HIV and syphilis testing with each full screen; discuss PrEP only if her risk profile indicates it.
Smoking is associated with BV, and stopping is one more modifiable factor for recurrence. Metronidazole product information advises avoiding alcohol during treatment and for 48 hours afterwards because of a possible disulfiram-like reaction (flushing, vomiting, palpitations) — the evidence is weak, but it remains the licensed advice.
Ask about plans for the next week — a birthday or wedding is when patients stop the course early. A vaginal gel option avoids most systemic effects if alcohol or nausea is a barrier. Offer smoking cessation support if she smokes.
Cervical screening detects high-risk HPV and pre-cancer in women without symptoms; it is not a diagnostic test for someone with symptoms. That is why post-coital bleeding needs the cervix examined even after a normal screening result — screening and symptom assessment are separate pathways.
Reinforce that her normal screening result is good news for the future, but does not answer today's question. Check HPV vaccination status (routine in the UK schools programme). Explain that the cervical examination today is about the bleeding, not a repeat smear.
| Cause | First-line (BASHH) | Pregnancy / breastfeeding | Partners | Follow-up |
|---|---|---|---|---|
| Bacterial vaginosis BASHH 2012 | Treat if symptomatic: metronidazole 400 mg BD for 5–7 days, or 2 g single dose; or metronidazole 0.75% gel 5 g nightly × 5; or clindamycin 2% cream 5 g nightly × 7. | Treat symptomatic BV; use 400 mg BD 5–7 days or a vaginal option — avoid the 2 g dose. Do not screen asymptomatic pregnant women (UK NSC). | Not routinely treated (BASHH 2012). | No test of cure if symptoms settle; swab if persistent or recurrent. |
| Vulvovaginal candidiasis BASHH 2019 | Fluconazole 150 mg oral stat, or clotrimazole 500 mg pessary stat (± clotrimazole 1% cream externally). | Topical only — clotrimazole pessary for up to 7 nights; avoid oral fluconazole. | Not routinely treated. | Recurrent (≥4/yr): culture to confirm, then fluconazole 150 mg every 72 h × 3, then 150 mg weekly for 6 months; HbA1c. |
| Trichomoniasis BASHH 2021 | Metronidazole 400–500 mg BD for 7 days. | Same 7-day regimen; avoid 2 g stat; inform the antenatal team. | Treat current partners simultaneously, whatever their result. | Abstain until both treated; full STI screen; test of cure if symptoms persist. |
| Chlamydia BASHH 2018 → 2026 | Doxycycline 100 mg BD for 7 days. | Azithromycin 1 g then 500 mg daily for 2 days (preferred), or 1 g single dose, erythromycin or amoxicillin (BASHH 2026); confirm with local sexual health. | Look back 6 months (all women); treat contacts without waiting for results. | Test of cure in pregnancy ≥3 weeks after treatment; retest under-25s at ~3 months (BASHH 2026: 2–6 months). |
| Gonorrhoea BASHH 2025 | Refer to GUM: culture first, then ceftriaxone 1 g IM single dose (monotherapy). | Ceftriaxone 1 g IM remains first-line; no quinolones; liaise with maternity team. | Look back 3 months (2 weeks for symptomatic male urethral infection). | Test of cure only where indicated (≥2 weeks); abstain until 7 days after all treated. |
| PID BASHH 2019 | Ceftriaxone 1 g IM stat, then doxycycline 100 mg BD + metronidazole 400 mg BD for 14 days — start the same day. | PID in pregnancy → admit; always exclude ectopic first. | Partners from the 6 months before symptom onset. | Review at 72 hours; again at 2–4 weeks. |
- Pregnancy test — she misses pills; this decides the regimen
- Vaginal pH on narrow-range paper from the lateral wall: >4.5 supports BV or trichomonas, ≤4.5 favours candida
- Self-taken vulvovaginal NAAT for chlamydia and gonorrhoea (± trichomonas NAAT, given the odour)
- HIV and syphilis serology offered; hepatitis B/C by risk
- Ask about pelvic pain, deep dyspareunia, fever — any PID feature changes the plan
- Oral metronidazole 400 mg BD — a 7-day course sits within the BASHH BV range and matches the trichomonas regimen while that result is pending
- Or a vaginal gel/cream if she prefers (clindamycin cream: condom warning)
- Do not give thrush treatment for a non-itchy, odorous, pH >4.5 discharge
- Treat chlamydia/gonorrhoea on the result, not blindly — unless PID features, mucopurulent cervicitis or a known positive contact
- Speculum examination with chaperone — today if she agrees, otherwise booked within days
- Cervix looks consistent with cancer → suspected cancer pathway referral (NICE NG12), whatever the screening history
- Cervicitis / contact bleeding → swabs, treat per result or presumptively per sexual health advice
- Ectropion (common on the combined pill) or normal cervix → reassure if bleeding settles; persistent unexplained PCB with negative tests → gynaecology/colposcopy per local pathway
"Take one tablet twice a day with food for the full course, even if things settle quickly. It can leave a metallic taste. Please don't drink any alcohol while you're taking it and for two days afterwards — it can make you feel very unwell."
SCA: state the alcohol warning, avoid the 2 g dose if pregnancy is possible, and explain that BV is not an STI and partners are not routinely treated — unlike trichomonas, where the partner must be treated.
"Use one applicator full at bedtime for seven nights. It can weaken condoms and diaphragms, so they won't protect you reliably while you're using it — we'll talk about what else to use."
SCA: offering a choice of route is shared decision-making; forgetting the condom warning is a safety omission.
"Insert the pessary high into the vagina at bedtime. The cream is for the outside if you're itchy or sore. If you're pregnant, use your finger rather than the applicator. If it isn't clearly better in a week, come back so we can take a swab rather than repeat the treatment."
SCA: recognising that repeated self-treated "thrush" often is not thrush is a key reasoning point; the cream is right only when the features fit.
"This is a single capsule. If you're on the weekly course, please use reliable contraception and tell us straight away if you might be pregnant — we'd switch you to a cream or pessary."
SCA: "Could you be pregnant?" before fluconazole is a safety question that scores. For recurrence, confirm the diagnosis and check HbA1c before committing to six months of treatment.
"Take it twice a day for a week with a full glass of water, sitting or standing, not just before bed. Use sun protection. No sex — including oral sex — until you've finished the course and your partner has been treated too. It doesn't affect your pill."
SCA: doxycycline replaced single-dose azithromycin as first-line in 2018 (more effective, particularly for rectal infection). Pair the prescription with partner notification and abstinence advice every time.
"This is a single dose. Because you're pregnant, we'll check the infection has gone with a repeat test in about three to four weeks. Your partner needs treating before you have sex again."
SCA: knowing the pregnancy switch and the test of cure is the difference between a pass and a strong pass.
"The sexual health clinic will take a sample to check which antibiotics work before giving you an injection. It's important to go — tablets alone are no longer reliable for gonorrhoea."
SCA: route positive gonorrhoea to GUM for culture, treatment, partner notification and test of cure rather than prescribing tablets.
Telling a partner
A positive STI result can feel like an accusation. Offer the options for partner notification — telling the partner herself, the clinic contacting partners anonymously, or a joint approach — and be clear that timing of infection usually cannot be determined. If there is any concern about abuse, partner notification is done by the service, not by the patient.
"You don't have to have this conversation alone. The sexual health team can contact your partner without giving your name."Shame and "being dirty"
BV and thrush are commonly misunderstood as hygiene problems, which drives more washing and more recurrence. Explicitly de-stigmatise: BV is a change in the balance of normal bacteria, candida is a normal inhabitant that overgrows, and neither reflects cleanliness.
"This isn't about being clean or not — washing more can actually make it worse. It's just the balance of the normal bacteria that has shifted."Fertility fears
Mentioning fertility can motivate testing but can also frighten. Put it in proportion: a treated chlamydia infection found early is very unlikely to cause problems; the risk lies in untreated or repeated infection and PID. Offer that perspective proactively if a result is positive.
"Finding it now and treating it is exactly what protects your fertility — it's infections that are missed for a long time that cause problems."Work and practicalities
This rarely needs time off work or a fit note. The practical barriers are appointments, results and the examination: offer text results, early or late slots, and direct booking with sexual health. Driving: there are no DVLA implications for these conditions or for the standard treatments.
"You won't need any time off for this. Let's make the follow-up fit around work — results by text, and an appointment time that suits you."Confidentiality and records
Worries about who can see the record — parents on the same practice list, a partner with access to her phone or NHS App — are common and legitimate. Explain what goes in the record, that sexual health clinics keep separate confidential records, and agree safe contact details.
"If you'd prefer, the sexual health clinic can do the tests, and their records are kept separately from your GP notes."Recurrence and frustration
Recurrent BV or thrush erodes quality of life, sex and confidence, and patients often cycle through pharmacy treatments. Validate the frustration, confirm the diagnosis properly, and offer a plan (triggers, route switch, suppression with specialist advice) rather than another identical prescription.
"If this keeps coming back, it deserves a proper plan — not just another box of the same thing."Today — test, treat the likely cause, plan the examination
Pregnancy test; pH; self-taken vulvovaginal NAAT (chlamydia/gonorrhoea ± trichomonas); HIV and syphilis serology offered. Treat likely BV if not pregnant and no PID features. Speculum examination with chaperone now or booked within days. Safeguarding and coercion questions documented. Agree how she will receive results. Contraception: missed pills, emergency contraception if indicated.
Within about a week — results and the examination
Check results are back and acknowledged; positive chlamydia → doxycycline (or azithromycin regimen if pregnant) + partner notification; positive gonorrhoea or trichomonas → sexual health for treatment and partner management. Examination completed: suspicious cervix → suspected cancer pathway referral (NG12); cervicitis treated; ectropion explained. If she did not attend for the examination, contact her — a missed examination for post-coital bleeding is a safety gap, not just a DNA.
72 hours — only if PID treatment was started
Review response to ceftriaxone + doxycycline + metronidazole (BASHH 2019). No improvement → reconsider diagnosis, consider admission and imaging. Check adherence to the 14-day course and that partners are being notified.
2–6 weeks — symptoms and test of cure where needed
BV: no test of cure if symptoms have settled; persistent symptoms → HVS Gram stain, TV NAAT, candida, look for a retained tampon or foreign body. Chlamydia in pregnancy: test of cure no sooner than 3 weeks after treatment. Gonorrhoea: test of cure where GUM advises. Post-coital bleeding: if it continues with a normal-looking cervix and negative tests → gynaecology/colposcopy referral per local pathway.
About 3 months — retest if chlamydia was positive
Under-25s who test positive for chlamydia are offered a retest for reinfection at around 3 months (NCSP; BASHH 2026 allows 2–6 months, and uptake is best when offered early). Offer a full screen at any new partner. Review recurrence of BV or thrush: triggers, route switch, and specialist input for suppression if frequent.
Memory rule — test of cure vs retest
Test of cure asks "did the treatment work?" — needed for chlamydia in pregnancy (≥3 weeks), gonorrhoea where GUM advises (≥2 weeks), and persistent symptoms. Retest asks "has she been reinfected?" — around 3 months after a positive chlamydia test in under-25s. BV and uncomplicated thrush need neither if symptoms settle. Post-coital bleeding is monitored until it has stopped or been referred.
| What | Who | When | Action threshold |
|---|---|---|---|
| NAAT results | Everyone tested | As soon as reported (usually days) | Positive → treat, partner notification, abstinence advice; unacknowledged results actively recalled |
| Pregnancy test | Any chance of pregnancy | Today; repeat ≥3 weeks after last unprotected sex | Positive + pain/bleeding → same-day early pregnancy assessment; positive → adjust all drug choices |
| Chlamydia test of cure | Pregnant; poor adherence; persistent symptoms | No sooner than 3 weeks after treatment | Positive → consider reinfection vs failure; discuss with sexual health |
| Gonorrhoea test of cure | Susceptibility unknown/reduced, pharyngeal, alternative regimen, pregnancy, persistent symptoms | ≥2 weeks after treatment (BASHH 2025) | Positive → urgent GUM; culture; report suspected resistance |
| Chlamydia reinfection retest | Under-25s positive for chlamydia | Around 3 months (BASHH 2026: 2–6 months) | Positive → retreat and revisit partner notification |
| PID response | On PID treatment | 72 hours; 2–4 weeks | No improvement → reassess, consider admission/imaging |
| BV / candida symptoms | Treated for BV or thrush | If persistent after treatment or recurring | Persistent → swab (Gram stain, culture/speciation, TV NAAT); ≥4 candida episodes/yr → confirm and induction–maintenance + HbA1c |
| Post-coital bleeding | Aisha | Examination within days; review at 4–6 weeks | Suspicious cervix → NG12 referral; persistent, cervix normal, tests negative → gynae/colposcopy |
| Safeguarding | Under-18s; any coercion concern | Every contact | Under 13, or exploitation/abuse indicators → safeguarding referral; no concern → document assessment |
⚠ Three scenario-specific phrases — use these verbatim
Why safety-netting matters beyond clinical care
- Treating without testing; no partner notification
- Ignoring the cervical red flag; no safety-net for PID/ectopic
- Missing contraception/prevention opportunity
Who you are
Aisha Rahman, 24, office worker. Three weeks of increased vaginal discharge — but it's "different from my usual thrush": more watery and there's a smell. You assumed it's thrush and want treatment so you can get on with your day. You feel a bit awkward talking about it. You've had a new partner for about two months and you haven't always used condoms. If asked sensitively, you'll admit you had some light bleeding after sex once last week, which you found a bit embarrassing and didn't want to bring up. Your first cervical screening test, three months ago, was normal. You're well otherwise — no fever, no bad pain. You're hesitant about being examined and would rather just take a tablet/cream and go.
Hidden concerns (reveal if explored)
STI worry (main, unspoken): deep down you're worried it might be an infection from the new partner, but you're embarrassed to say so. If the doctor is non-judgmental and confidential, you open up.
The bleeding: you didn't want to mention it; if asked directly and gently, you'll admit it. If the doctor explains why they want to look, you'll agree to an exam.
Privacy: you're worried about confidentiality. Reassurance helps a lot.
Clinical details if asked
- Discharge: watery, greyish, with an odour; no real itch; "not like my usual thrush"
- One episode of light post-coital bleeding last week; no bleeding between periods otherwise
- New partner ~2 months; inconsistent condom use; male partner; no other recent partners
- No fever, no severe pelvic pain; mild discomfort only
- Last menstrual period ~2 weeks ago; on the pill (sometimes misses one); could you be pregnant? unlikely but not certain
- First cervical screening test three months ago: normal (HPV negative); up to date with HPV vaccine; no past STIs that you know of
- You feel safe in the relationship; partner is a similar age
Reactions at key moments
- On being asked about sex: initially a bit guarded; opens up if the doctor is warm and non-judgmental.
- On the self-swab: relieved you can do it yourself; happy to.
- On examination for the bleeding: hesitant, but agree if it's explained and you're reassured you're in control.
- Challenge line: "Can't you just give me the cream? I don't really want all these tests and an examination."
Resolution: Aisha is satisfied if the GP: (1) creates a confidential, non-judgmental space and takes a sexual history; (2) recognises the picture isn't simple thrush and offers a self-taken NAAT + full STI screen, explaining why; (3) gently elicits and acts on the post-coital bleeding — examining the cervix and explaining the NG12 pathway if it looks suspicious, not reassuring on the normal smear alone; (4) handles partner notification and prevention sensitively; (5) safety-nets for PID/ectopic. She disengages if she feels judged, rushed, or is simply handed thrush cream with the bleeding ignored.
- Possible ectopic (pain/bleeding + ?pregnant)
- Severe PID / sepsis / TOA
- Acute safeguarding risk
- Suspicious cervix → NG12; persistent unexplained PCB/IMB → gynae/colposcopy
- PID (clinical) → empirical Rx
- Safeguarding concern
- BV / candida
- STI screen & treat
BV: thin grey, fishy, pH>4.5 → metronidazole. Candida: white, itchy, normal pH → azole; recurrent → maintenance + diabetes screen.
NAAT self-swab + HIV/syphilis by risk. Chlamydia → doxycycline; gonorrhoea → ceftriaxone (culture); trichomonas → metronidazole. PID → empirical antibiotics, low threshold. Partner notification + test of cure. PCB/suspicious cervix → examine + NG12.